Central America Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
73 Pages - SKU: BMI5329127
Countries covered: Central America

Central America Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namelyEl Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapitamedicine spending and strong consumer demand still present strong revenue-generatingopportunities for multimodal pharmaceutical companies.

Headline Expenditure Projections

Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to less promising industry data.

Healthcare: USD16.0bn in 2013 to USD16.8bn in 2014; +4.8 %. Our forecast has been reviseddownwards since Q314 due to revised historical data.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014BMI View: We expect Uzbekistan's healthcare spending to continue outpacing the country's economicgrowth, creating opportunities for most health ...
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014BMI View: The UAE continues to appeal to businesses thanks to its growing economy, which willincreasingly ...
Pharmaceuticals and Healthcare Report - South Africa Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - South Africa Q4 2014BMI View: South Africa's tepid economic growth, depreciating currency and current account deficit willlimit the market potential ...
Pharmaceuticals and Healthcare Report - Serbia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Serbia Q4 2014BMI View: In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50%through a new ...
See all reports like this >>

More Central America Prescription Drugs reports

Antibiotics Market in Panama to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Panama. The study provides essential market ...
See all reports like this >>

More Central America reports

D&B Country Report: Guatemala by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
D&B Country Report: El Salvador by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!